Resultados: 32

    The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance

    The specific objectives were to evaluate the harms to benefits ratio of delamanid in combination with the currently recommended MDR-TB treatment regimen in children. Based on this evaluation, to develop recommendations on the use of delamanid as part of WHO-recommended longer MDR-TB treatment regimens, a...

    The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance

    Tuberculosis (TB) remains a large-scale public health problem. Key global priorities for TB care and control include improving case-detection and detecting patients earlier, particularly patients with smear-negative TB disease. This document provides a pragmatic summary of the evidence and recommendation...

    Guideline: Infant feeding in areas of Zika virus transmission

    Zika virus is a mosquito-borne virus transmitted by Aedes mosquitoes; the same mosquito also transmits other vector-borne diseases – dengue, chikungunya and yellow fever. Purpose of the guideline The purpose of this guideline is to provide a recommendation to guide governments, ministries of health, po...

    WHO treatment guidelines for drug-resistant tuberculosis, 2016 update

    In November 2015, the World Health Organization (WHO) convened a meeting of a Guideline Development Group (GDG) for the update of policy recommendations on the treatment of drug-resistant TB. The GDG was composed of a multidisciplinary group of tuberculosis (TB) and drug-resistant TB experts external to ...

    Screening, assessment and management of neonates and infants with complications associated with Zika virus exposure in utero

    This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigation an...

    Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis

    Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations that wo...

    Guideline: daily iron supplementation in infants and children

    This guideline provides global, evidence-informed recommendations on daily iron supplementation in infants and children, as a public-health intervention for the prevention of anaemia and iron deficiency. It includes recommendations for iron supplementation in countries where malaria is prevalent. The gui...

    Guideline: daily iron supplementation in adult women and adolescent girls

    This guideline provides a global, evidence-informed recommendation on daily iron supplementation in menstruating adult women and adolescents, as a public-health intervention for the prevention of anaemia and iron deficiency. The guideline aims to help Member States and their partners in their efforts to ...

    WHO guidelines for the treatment of Chlamydia trachomatis

    Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated trea...

    WHO guidelines for the treatment of genital herpes simplex virus

    Rationale for the guidelines: Since the publication of the World Health Organization (WHO) Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These gui...